Navigation Links
Safinamide Phase III Study Results Presented at 2013 MDS Meeting
Date:6/18/2013

ence of treatment emergent abnormalities in laboratory results, ophthalmological examinations, vital signs and ECG was similar in all groups.

Analyses (On treatment, ANCOVA-LOCF) performed in the ITT population showed treatment with safinamide 50-100 mg/day significantly improved ON-Time without troublesome dyskinesia compared to placebo by 0.96 ± 0.21 hours (p<0.01) in the ITT. Significant benefits of safinamide 50-100 mg/day were also reported in OFF-time, Motor symptoms (UPDRS III), PDQ39, EQ-5D, clinical global impression of change and severity, and OFF-time post morning dose of levodopa.

The abstract presented at the MDS is available for download at: http://www.newron.com/ENG/Default.aspx?SEZ=5&PAG=122 and

http://http://www.zambonpharma.com

About safinamide

Safinamide, an alpha-aminoamide, is currently being developed by Newron as an add-on therapy to dopamine agonists or to levodopa in patients with early or mid- to late-stage Parkinson's disease (PD). It is believed to have both dopaminergic and non dopaminergic activities, including selective and reversible inhibition of monoamine oxidase B (MAO-B), activity-dependent sodium channel antagonism and inhibition of glutamate release in vitro.

About Newron Pharmaceuticals

Newron (SIX: NWRN) is a biopharmaceutical company focused on novel therapies for diseases of the Central Nervous System (CNS) and pain. The Company is headquartered in Bresso near Milan, Italy. Based on the phase III results of safinamide for treatment of Parkinson's disease, Newron is working to expedite the global filing of the compound, together with its partners. Zambon Group has the rights to commercialise safinamide globally, excluding Japan and other key Asian territories, and Meiji Seika'/>"/>

SOURCE Newron Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
2. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
3. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
4. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
5. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
6. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimers Disease
7. NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinsons Disease and Movement Disorders
8. Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
9. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
10. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
11. SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Drug Delivery in ... Companies" to their offering. ... the BBB have opened new avenues and possibilities ... carrier or transport systems, enzymes, and receptors that ...
(Date:9/2/2015)... Demers Ambulances is proud to announce it has ... for the states of Mississippi , ... "This will enable Demers to effectively meet ... Executive Vice-President for Demers Ambulances. "Emergency Equipment Professionals has three ... Alabama , giving them a strategic advantage. ...
(Date:9/2/2015)... , Sept. 2, 2015  MiMedx Group, Inc. ... company utilizing human amniotic tissue and patent-protected processes ... for the Wound Care, Surgical, Orthopedic, Spine, Sports ... corrected the inaccurate statements published by the Musculoskeletal ... September 1, 2015. MTF,s September 1st ...
Breaking Medicine Technology:Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2MiMedx Corrects A Second Inaccurate MTF Press Release 2MiMedx Corrects A Second Inaccurate MTF Press Release 3
... 9 ARmark Authentication Technologies, LLC, and Colorcon, ... and introduction of ®mark® On-Dose ID(TM) , ... into the immediate-release film coatings of solid oral ... provides Colorcon exclusive rights to market ARmark,s micro-tags ...
... , ALISO VIEJO, Calif., Nov. 9 Clarient, Inc. (Nasdaq: ... pathologists, oncologists and the pharmaceutical industry, today announced that it ... in New York City. , The first presentation will be ... at 1:40 pm EST on Tuesday, November 17. The conference ...
Cached Medicine Technology:ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2
(Date:9/2/2015)... ... September 02, 2015 , ... A recent survey by Consumer Reports ( ... and its negative impact on consumers. It was reported that 33% are paying an ... as much as an extra $100 compared to last year. Among the drugs that ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... products, announces Hand Free Pocket Cop, a safety invention that protects people from ... is worth $31 billion," says Scott Cooper, CEO and Creative Director of World ...
(Date:9/2/2015)... Las Vegas, NV (PRWEB) , ... September 02, ... ... Las Vegas and Fort Lauderdale, CENTURION SERVICE GROUP is internationally known as an ... largest medical auction house in the world, selling more than 100,000 pieces of ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Ovarian cancer ... Society, a woman’s risk of getting ovarian cancer in her lifetime is approximately 1 ... new diagnosis of ovarian cancer, and 14,000 will die. , There is no ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... center, is helping to bring awareness to International Overdose Awareness Day. The goal ... pause to recognize the warning signs so that they may get help. ...
Breaking Medicine News(10 mins):Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:August 31 is International Overdose Awareness Day – Lakeview Health to Help Bring Awareness 2
... their lifetime, women have more than a 12 percent risk ... week, research on novel approaches to breast cancer treatment is ... scientific meeting hosted by the Department of Defense Breast Cancer ... for everyone, and alternative methods and delivery systems for breast ...
... a fast, inexpensive urine test to detect and monitor the ... rampage in the developing world. Their study appears in the ... led by Virander Singh Chauhan and Ranjan Kumar Nanda notes ... 3 million each year, mostly in developing countries. Health care ...
... Reporter , TUESDAY, Aug. 2 (HealthDay News) -- There,s still ... a way to shorten its misery: A new study suggests ... cut the length of colds by more than 40 percent. ... in Finland, reviewed 13 placebo-controlled trials examining the effect of ...
... the nation,s largest interdisciplinary organization devoted to the ... of the University of California, Irvine, as the 2011 ... This distinguished honor recognizes insightful and innovative publications ... and social sciences. It is underwritten by the Baywood ...
... , TUESDAY, Aug. 2 (HealthDay News) -- Americans used to ... the case, according to a new study that gives high-income ... in particular, and obesity are to blame, said the U.S. ... expectancy in coming years and help to reduce health care ...
... elevated blood levels of a potentially toxic protein in women ... the therapeutic dilemma posed by the condition balancing life-threatening ... poses to an immature fetus. In a paper receiving ... of U.S. and German researchers report promising results from their ...
Cached Medicine News:Health News:Fighting breast cancer from new angles 2Health News:Fighting breast cancer from new angles 3Health News:Fighting breast cancer from new angles 4Health News:Fighting breast cancer from new angles 5Health News:Larger Dose of Zinc Lozenges May Shorten Colds 2Health News:Charles to receive GSA's 2011 Richard Kalish Innovative Publication Award 2Health News:Americans No Longer Outliving Europeans: Study 2Health News:Pilot study suggests new approach to treat preeclampsia 2Health News:Pilot study suggests new approach to treat preeclampsia 3
For accurately monitoring core temperature and heart and breath sounds as well as for gastric suctioning....
For accurately monitoring core temperature and heart and breath sounds....
... Level 1 enables hospitals ... patient monitors to a ... Our temperature monitoring disposale ... are superior in their ...
... Level 1 enables ... multiparameter patient monitors to ... series. Our temperature monitoring ... cables are superior in ...
Medicine Products: